Rhumbline Advisers Global Blood Therapeutics, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$32.4 - $68.18 $514,965 - $1.08 Million	15,894 Added 21.64%	89,339 $6.08 Million
Q2 2022 Aug 11, 2022	BUY	$22.3 - $37.39 $188,791 - $316,543	8,466 Added 13.03%	73,445 $2.35 Million
Q1 2022 May 12, 2022	BUY	$25.68 - $35.59 $48,175 - $66,766	1,876 Added 2.97%	64,979 $2.25 Million
Q4 2021 Feb 10, 2022	BUY	$24.9 - $40.26 $5,876 - $9,501	236 Added 0.38%	63,103 $1.85 Million
Q3 2021 Nov 12, 2021	BUY	$25.48 - $37.34 $47,825 - $70,087	1,877 Added 3.08%	62,867 $1.6 Million
Q2 2021 Aug 05, 2021	BUY	$32.46 - $43.42 $24,572 - $32,868	757 Added 1.26%	60,990 $2.14 Million
Q1 2021 May 06, 2021	SELL	$38.94 - $50.85 $129,436 - $169,025	-3,324 Reduced 5.23%	60,233 $2.45 Million
Q4 2020 Feb 10, 2021	SELL	$37.65 - $63.77 $96,986 - $164,271	-2,576 Reduced 3.9%	63,557 $2.75 Million
Q3 2020 Nov 12, 2020	SELL	$52.76 - $74.49 $197,269 - $278,518	-3,739 Reduced 5.35%	66,133 $3.65 Million
Q2 2020 Aug 13, 2020	SELL	$48.73 - $81.82 $741,426 - $1.24 Million	-15,215 Reduced 17.88%	69,872 $4.41 Million
Q1 2020 May 06, 2020	BUY	$41.72 - $87.2 $114,437 - $239,189	2,743 Added 3.33%	85,087 $4.35 Million
Q4 2019 Feb 05, 2020	BUY	$45.7 - $81.86 $179,326 - $321,218	3,924 Added 5.0%	82,344 $6.55 Million
Q3 2019 Oct 23, 2019	BUY	$45.35 - $57.91 $30,429 - $38,857	671 Added 0.86%	78,420 $3.81 Million
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $379,772 - $456,953	7,220 Added 10.24%	77,749 $4.09 Million
Q1 2019 May 01, 2019	BUY	$39.99 - $53.48 $161,879 - $216,487	4,048 Added 6.09%	70,529 $3.73 Million
Q4 2018 Jan 31, 2019	BUY	$31.54 - $46.67 $671,865 - $994,164	21,302 Added 47.15%	66,481 $2.73 Million
Q3 2018 Nov 07, 2018	SELL	$38.0 - $51.1 $130,682 - $175,732	-3,439 Reduced 7.07%	45,179 $1.72 Million
Q2 2018 Aug 06, 2018	BUY	$38.7 - $50.15 $488,471 - $632,993	12,622 Added 35.07%	48,618 $2.2 Million
Q1 2018 May 02, 2018	SELL	$39.6 - $65.9 $40,154 - $66,822	-1,014 Reduced 2.74%	35,996 $1.74 Million
Q4 2017 Feb 09, 2018	SELL	$29.7 - $45.7 $170,210 - $261,906	-5,731 Reduced 13.41%	37,010 $1.46 Million
Q3 2017 Nov 06, 2017	BUY	$25.1 - $31.05 $1.07 Million - $1.33 Million	42,741	42,741 $1.33 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account